
ST3GAL4 Protein, Human, Recombinant (HA, His) NEW
Price | $698 |
Package | 100μg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-07-22 |
Product Details
Product Name: ST3GAL4 Protein, Human, Recombinant (HA, His) | Supply Ability: 10g |
Release date: 2025/07/22 |
Product Introduction
Bioactivity
Name | ST3GAL4 Protein, Human, Recombinant (HA, His) |
Description | ST3GAL4 gene expression is altered in different cancer types, including cervical cancer. Several mRNA transcripts have been reported for this gene. ST3GAL4 encodes for β?galactosidase α?2,3?sialyltransferase 4, involved in the biosynthesis of the tumour antigens sLe(x) and sulfo?sLe(x). |
Storage | store at low temperature | Shipping with blue ice/Shipping at ambient temperature. |
Keywords | STZSIAT-4 | STZSIAT 4 | ST4 | ST 4 | SIAT-4 | SIAT 4 | SAT 3 | NANTA-3 | NANTA 3 | CGS-23 | CGS 23 |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$336.00/20μg |
VIP1Y
|
TargetMol Chemicals Inc.
|
2025-06-24 | |
$700.00/100μg |
VIP5Y
|
TargetMol Chemicals Inc.
|
2024-10-23 | |
$70.00/1kg |
VIP3Y
|
Zibo Hangyu Biotechnology Development Co., Ltd
|
2023-11-27 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, USA
INQUIRY